Your browser doesn't support javascript.
loading
Hypo-METRICS: Hypoglycaemia-MEasurement, ThResholds and ImpaCtS-A multi-country clinical study to define the optimal threshold and duration of sensor-detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health economic outcomes: The study protocol.
Divilly, Patrick; Zaremba, Natalie; Mahmoudi, Zeinab; Søholm, Uffe; Pollard, Daniel J; Broadley, Melanie; Abbink, Evertine J; de Galan, Bastiaan; Pedersen-Bjergaard, Ulrik; Renard, Eric; Evans, Mark; Speight, Jane; Brennan, Alan; McCrimmon, Rory J; Müllenborn, Matthias; Heller, Simon; Seibold, Alexander; Mader, Julia K; Amiel, Stephanie A; Pouwer, Frans; Choudhary, Pratik.
Afiliação
  • Divilly P; Department of Diabetes, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Zaremba N; Department of Diabetes, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Mahmoudi Z; Department of Diabetes, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Søholm U; Digital Therapeutics, Scientific Modelling, Novo Nordisk A/S, Søborg, Denmark.
  • Pollard DJ; Department of Diabetes, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Broadley M; Department of Psychology, University of Southern Denmark, Odense, Denmark.
  • Abbink EJ; School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
  • de Galan B; Department of Psychology, University of Southern Denmark, Odense, Denmark.
  • Pedersen-Bjergaard U; Department of internal medicine, Radboud university medical centre, Nijmegen, The Netherlands.
  • Renard E; Department of internal medicine, Radboud university medical centre, Nijmegen, The Netherlands.
  • Evans M; Department of Internal Medicine, Division of Endocrinology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Speight J; CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
  • Brennan A; Department of Endocrinology and Nephrology, Nordsjaellands Hospital Hillerød, Hillerød, Denmark.
  • McCrimmon RJ; Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Müllenborn M; Department of Endocrinology, Diabetes, Nutrition, Montpellier University Hospital, Montpellier, France.
  • Heller S; Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.
  • Seibold A; Wellcome Trust-MRC Institute of Metabolic Science and Department of Medicine, University of Cambridge, UK.
  • Mader JK; School of Psychology, Deakin University, Geelong, Australia.
  • Amiel SA; The Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria, Melbourne, Australia.
  • Pouwer F; School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
  • Choudhary P; Systems Medicine, School of Medicine, University of Dundee, Dundee, UK.
Diabet Med ; 39(9): e14892, 2022 09.
Article em En | MEDLINE | ID: mdl-35633291
ABSTRACT

INTRODUCTION:

Hypoglycaemia is a significant burden to people living with diabetes and an impediment to achieving optimal glycaemic outcomes. The use of continuous glucose monitoring (CGM) has improved the capacity to assess duration and level of hypoglycaemia. The personal impact of sensor-detected hypoglycaemia (SDH) is unclear. Hypo-METRICS is an observational study designed to define the threshold and duration of sensor glucose that provides the optimal sensitivity and specificity for events that people living with diabetes experience as hypoglycaemia.

METHODS:

We will recruit 600

participants:

350 with insulin-treated type 2 diabetes, 200 with type 1 diabetes and awareness of hypoglycaemia and 50 with type 1 diabetes and impaired awareness of hypoglycaemia who have recent experience of hypoglycaemia. Participants will wear a blinded CGM device and an actigraphy monitor to differentiate awake and sleep times for 10 weeks. Participants will be asked to complete three short surveys each day using a bespoke mobile phone app, a technique known as ecological momentary assessment. Participants will also record all episodes of self-detected hypoglycaemia on the mobile app. We will use particle Markov chain Monte Carlo optimization to identify the optimal threshold and duration of SDH that have optimum sensitivity and specificity for detecting patient-reported hypoglycaemia. Key secondary objectives include measuring the impact of symptomatic and asymptomatic SDH on daily functioning and health economic outcomes. ETHICS AND DISSEMINATION The protocol was approved by local ethical boards in all participating centres. Study results will be shared with participants, in peer-reviewed journal publications and conference presentations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Hipoglicemia Tipo de estudo: Diagnostic_studies / Guideline / Health_economic_evaluation / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Diabet Med Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Hipoglicemia Tipo de estudo: Diagnostic_studies / Guideline / Health_economic_evaluation / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Diabet Med Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido